Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France
Author:
Funder
Institut National Du Cancer
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference21 articles.
1. Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data;Meulendijks;Lancet Oncol,2015
2. Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time;Lunenburg;Eur J Cancer,2016
3. DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update;Henricks;Ann Oncol,2017
4. 5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency;Boisdron-Celle;Cancer Lett,2007
5. Upfront genotyping of DPYD*2A to individualize fluoropyrimidine therapy: a safety and cost analysis;Deenen;J Clin Oncol,2016
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy;Strahlentherapie und Onkologie;2024-09-04
2. Extracts from Microalgae and Archaea from the Andalusian Coast: A Potential Source of Antiproliferative, Antioxidant, and Preventive Compounds;Journal of Marine Science and Engineering;2024-06-14
3. Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants;JCO Precision Oncology;2024-05
4. Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis;British Journal of Cancer;2024-01-15
5. Impact of hemolysis on uracilemia in the context of dihydropyrimidine dehydrogenase deficiency testing;Clinical Chemistry and Laboratory Medicine (CCLM);2024-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3